
Liraglutide and Dulaglutide Have Comparable HbA1c Reduction in Emirati Patients with T2DM
Author(s) -
Aml Mohamed Nada,
Maher Y. A. Younan
Publication year - 2021
Publication title -
open journal of endocrine and metabolic diseases
Language(s) - English
Resource type - Journals
eISSN - 2165-7432
pISSN - 2165-7424
DOI - 10.4236/ojemd.2021.114008
Subject(s) - liraglutide , medicine , dulaglutide , endocrinology , renal function , diabetes mellitus , type 2 diabetes , blood pressure , body mass index , urology , gastroenterology